跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
MS CONTIN 5mg tablet
Approved
STANDARD
MS CONTIN 5mg tablet
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c8cc45556a4102c3
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
c8cc45556a4102c3
Product Name
MS CONTIN 5mg tablet
Artg Id
51760
Artg Name
MS CONTIN morphine sulfate pentahydrate 5mg modified release tablet blister pack
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
1995-03-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8544e0aa3b8f286dc8459d5448550911.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dab437328703a88c93538b671ee934bc.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c8cc45556a4102c3
Type
Standard
Back to TGA Approvals
MS CONTIN 5mg tablet - TGA Drug Approval Details